{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"groups":[{"description":"Participants who chose to continue vaginal testosterone therapy upon completion of the study.","id":"OG000","title":"Continued Vaginal Testosterone Therapy"},{"description":"Participants who chose not to continue vaginal testosterone upon completion of the study.","id":"OG001","title":"Did Not Continue Vaginal Testosterone Therapy"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"After 4 weeks","title":"Number of Participants Who Continued Vaginal Testosterone Upon Completion of the Study","type":"SECONDARY","unitOfMeasure":"participants"}